GenScript Biotech Corporation is a global biotechnology contract research organization (CRO) and the world's leader in molecular cloning, gene synthesis, peptide synthesis, protein and antibody engineering. Founded in 2002 in Piscataway, New Jersey by Dr. Frank Zhang and partners, GenScript is now headquartered in Nanjing, China, with operations across North America, Europe, China and Asia Pacific. The company is publicly listed on the Hong Kong Stock Exchange (1548.HK) and reported FY2024 revenues of approximately US$959.5M.